Synthesis and antiviral activity of new dimeric inhibitors against HIV-1

Bioorg Med Chem. 2008 Jan 1;16(1):511-7. doi: 10.1016/j.bmc.2007.09.015. Epub 2007 Sep 14.

Abstract

This paper describes the synthesis and the antiviral activities of dimeric compounds derived from homo and asymmetric combinations of N-1 propynyloxymethyl analogues 1a,b of MKC-442, an N-1 4-iodobenzyloxymethyl analogue of TNK-651 5, potent contraceptive norgestrel and AZT. They were obtained by Sonogashira reaction, 'click' chemistry or Pd-catalyzed oxidative coupling. The iodo precursor 5 turned out as a potent compound against wild type and mutated HIV-1 virus. All dimeric compounds showed lower activity against HIV-1 than MKC-442, except the asymmetric dimer of AZT and 1a which showed an activity comparable to MKC-442.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / chemical synthesis*
  • Anti-HIV Agents / pharmacology
  • Dimerization
  • HIV-1 / drug effects*
  • HIV-1 / genetics
  • Humans
  • Mutation
  • Pyrimidines / chemistry
  • Pyrimidines / pharmacology
  • Uracil / analogs & derivatives
  • Uracil / chemistry
  • Uracil / pharmacology
  • Zidovudine / chemistry
  • Zidovudine / pharmacology

Substances

  • Anti-HIV Agents
  • Pyrimidines
  • TNK-651
  • Zidovudine
  • Uracil
  • emivirine